3-Mar-2025
Here's the major earnings before the open tomorrow
Seeking Alpha News (Mon, 3-Mar 6:00 PM ET)
Seeking Alpha News (Mon, 3-Mar 9:24 AM ET)
Craig-Hallum Reaffirms Their Buy Rating on Genius Sports Limited (GENI)
TipRanks (Mon, 3-Mar 9:02 AM ET)
Lake Street Sticks to Their Buy Rating for Genius Sports Limited (GENI)
TipRanks (Mon, 3-Mar 8:58 AM ET)
Business Wire (Mon, 3-Mar 8:45 AM ET)
Catalyst Watch: Tariff reality, Target earnings volatility, and the February Jobs Report
Seeking Alpha News (Fri, 28-Feb 3:00 PM ET)
Catalyst Watch: Tariff reality, Target earnings volatility, and the February jobs report
Seeking Alpha News (Fri, 28-Feb 3:00 PM ET)
The Las Vegas Strip breaks out of its slump with strong gaming revenue in January
Seeking Alpha News (Thu, 27-Feb 11:37 AM ET)
Genius Sports to Announce Fourth Quarter and Full Year 2024 Results on March 4
Business Wire (Fri, 14-Feb 7:00 AM ET)
Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas including Sports Technology and Services; Betting Technology, Content and Services; and Media Technology, Content and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content and Services division. Geographically, the company derives a majority of its revenue from Europe.
Genius Sports trades on the NYSE stock market under the symbol GENI.
As of March 3, 2025, GENI stock price declined to $8.32 with 6,735,689 million shares trading.
GENI has a beta of 1.48, meaning it tends to be more sensitive to market movements. GENI has a correlation of 0.15 to the broad based SPY ETF.
GENI has a market cap of $1.90 billion. This is considered a Small Cap stock.
Last quarter Genius Sports reported $120 million in Revenue and $.05 earnings per share. This beat revenue expectation by $1 million and exceeded earnings estimates by $.06.
In the last 3 years, GENI traded as high as $10.33 and as low as $2.20.
The top ETF exchange traded funds that GENI belongs to (by Net Assets): ARKW, BETZ, TMAT, GWX, PRFZ.
GENI has outperformed the market in the last year with a return of +20.9%, while the SPY ETF gained +16.7%. However, in the most recent history, GENI shares have underperformed the stock market with its stock returning -14.8% in the last 3 month period and -15.4% for the last 2 week period, while SPY has returned -2.2% and -4.3%, respectively.
GENI support price is $8.37 and resistance is $8.99 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GENI shares will trade within this expected range on the day.